CN104114524B - 用于食欲肽-2受体拮抗剂的合成的方法和化合物 - Google Patents
用于食欲肽-2受体拮抗剂的合成的方法和化合物 Download PDFInfo
- Publication number
- CN104114524B CN104114524B CN201380009575.3A CN201380009575A CN104114524B CN 104114524 B CN104114524 B CN 104114524B CN 201380009575 A CN201380009575 A CN 201380009575A CN 104114524 B CN104114524 B CN 104114524B
- Authority
- CN
- China
- Prior art keywords
- formula
- compound
- alkyl
- prepared
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CC1[C@@](C)(*)NC(P)=C(*)C1 Chemical compound CC1[C@@](C)(*)NC(P)=C(*)C1 0.000 description 9
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
- C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/42—Separation; Purification; Stabilisation; Use of additives
- C07C303/44—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C07C309/66—Methanesulfonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/36—Polyhydroxylic alcohols containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/03—Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/12—Acetic acid esters
- C07C69/16—Acetic acid esters of dihydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261600109P | 2012-02-17 | 2012-02-17 | |
| US61/600109 | 2012-02-17 | ||
| US61/600,109 | 2012-02-17 | ||
| PCT/US2013/026204 WO2013123240A1 (en) | 2012-02-17 | 2013-02-14 | Methods and compounds useful in the synthesis of orexin-2 receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104114524A CN104114524A (zh) | 2014-10-22 |
| CN104114524B true CN104114524B (zh) | 2016-08-17 |
Family
ID=47755050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201380009575.3A Active CN104114524B (zh) | 2012-02-17 | 2013-02-14 | 用于食欲肽-2受体拮抗剂的合成的方法和化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US9416109B2 (enExample) |
| EP (1) | EP2814798B1 (enExample) |
| JP (1) | JP6147279B2 (enExample) |
| CN (1) | CN104114524B (enExample) |
| BR (1) | BR112014019909B1 (enExample) |
| CA (1) | CA2861493C (enExample) |
| ES (1) | ES2733750T3 (enExample) |
| HU (1) | HUE043995T2 (enExample) |
| IL (1) | IL232949A (enExample) |
| MX (1) | MX352881B (enExample) |
| RU (1) | RU2617696C2 (enExample) |
| SG (1) | SG11201403216UA (enExample) |
| WO (1) | WO2013123240A1 (enExample) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3983340B1 (en) * | 2019-06-12 | 2023-08-02 | Nouryon Chemicals International B.V. | Method for isolating carboxylic acid from an aqueous side stream |
| US11976034B2 (en) | 2019-06-12 | 2024-05-07 | Nouryon Chemicals International B.V. | Process for the production of diacyl peroxides |
| US11976035B2 (en) | 2019-06-12 | 2024-05-07 | Nouryon Chemicals International B.V. | Process for the production of diacyl peroxides |
| US12209065B2 (en) | 2019-06-12 | 2025-01-28 | Nouryon Chemicals International B.V. | Process for the production of diacyl peroxides |
| US12215074B2 (en) | 2019-06-12 | 2025-02-04 | Nouryon Chemicals International B.V. | Process for the production of peroxyesters |
| CN119930526A (zh) * | 2025-04-07 | 2025-05-06 | 东北制药集团股份有限公司 | 一种莱博雷生中间体的制备方法 |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2672732T3 (es) | 2012-02-07 | 2018-06-15 | Eolas Therapeutics Inc. | Prolinas/piperidinas sustituidas como antagonistas del receptor de orexina |
| US9440982B2 (en) | 2012-02-07 | 2016-09-13 | Eolas Therapeutics, Inc. | Substituted prolines/piperidines as orexin receptor antagonists |
| WO2013123240A1 (en) * | 2012-02-17 | 2013-08-22 | Eisai R&D Management Co., Ltd | Methods and compounds useful in the synthesis of orexin-2 receptor antagonists |
| RU2681937C2 (ru) | 2014-08-06 | 2019-03-14 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Способ получения пиримидин-1-олового соединения и его промежуточного соединения |
| UY36272A (es) | 2014-08-13 | 2016-02-29 | Eolas Therapeutics Inc | Difluoropirrolidinas como moduladores de los receptores de orexinas |
| TWI710557B (zh) | 2016-02-12 | 2020-11-21 | 美商伊歐拉斯治療學公司 | 作為食慾素受體調節劑之經鹵素取代之六氫吡啶 |
| JP7179049B2 (ja) * | 2017-08-01 | 2022-11-28 | ベルゲン ファーマシューティカル、 エルエルシー | オレキシン受容体拮抗薬の結晶形及びその製造方法並びに用途 |
| GB201807898D0 (en) * | 2018-05-15 | 2018-06-27 | Kancera Ab | New processes and products with increased chiral purity |
| US12098137B2 (en) | 2018-09-07 | 2024-09-24 | Sumitomo Chemical Company, Limited | Method for manufacturing cyclopropane compound |
| ES3013667T3 (en) * | 2019-05-15 | 2025-04-14 | Eisai R&D Man Co Ltd | Method and compound useful in preparation of orexin-2 receptor antagonist, and lemborexant having few impurities |
| WO2020263253A1 (en) * | 2019-06-26 | 2020-12-30 | Moline Margaret | Lemborexant for treating sleep issues |
| WO2021119223A1 (en) | 2019-12-11 | 2021-06-17 | Teva Czech Industries S.R.O. | Solid state form of lemborexant |
| JP2023508011A (ja) | 2019-12-20 | 2023-02-28 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 不眠症を治療するためのレンボレキサントの使用 |
| JPWO2021145373A1 (enExample) | 2020-01-16 | 2021-07-22 | ||
| ES2933074B2 (es) * | 2021-07-26 | 2023-09-29 | Moehs Iberica Sl | Procedimiento de sintesis de 2,4-dimetilpirimidin-5-ol, nuevos intermedios de dicho procedimiento y uso del producto en la sintesis de lemborexant |
| CN118871427A (zh) * | 2022-03-25 | 2024-10-29 | 浙江华海药业股份有限公司 | 一种莱博雷生及其中间体的制备方法 |
| WO2023178702A1 (zh) * | 2022-03-25 | 2023-09-28 | 浙江华海药业股份有限公司 | 莱博雷生及其中间体化合物的制备方法 |
| CN114778745B (zh) * | 2022-06-21 | 2022-09-16 | 南京威凯尔生物医药科技有限公司 | 一种高效液相色谱法检测仑布雷生中间体及其对映体杂质的方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008057575A2 (en) * | 2006-11-07 | 2008-05-15 | Dov Pharmaceutical, Inc. | Novel arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use |
| WO2008150364A1 (en) * | 2007-05-23 | 2008-12-11 | Merck & Co., Inc. | Cyclopropyl pyrrolidine orexin receptor antagonists |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2302994A1 (fr) * | 1975-03-06 | 1976-10-01 | Fabre Sa Pierre | Procede de preparation d'acides aryl-1, hydroxy methyl-2 cyclopropanes carboxyliques et de leurs lactones utiles comme intermediaires de synthese dans l'industrie pharmaceutique |
| US5849954A (en) * | 1996-01-18 | 1998-12-15 | Research Corporation Technologies, Inc. | Method of peptide synthesis |
| WO2004037212A2 (en) | 2002-10-24 | 2004-05-06 | Sepracor, Inc. | Compositions comprising zopiclone derivatives and methods of making and using the same |
| AU2008257411B2 (en) * | 2007-05-23 | 2012-04-26 | Merck Sharp & Dohme Corp. | Pyridyl piperidine orexin receptor antagonists |
| EP2350017A1 (en) | 2008-09-18 | 2011-08-03 | Pfizer Limited | Amide compounds useful in therapy |
| CA2745420A1 (en) | 2008-12-02 | 2010-06-10 | Glaxo Group Limited | N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0] hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof |
| FR2941454B1 (fr) * | 2009-01-29 | 2011-04-01 | Pf Medicament | Proced de synthese du (1s,2r)-milnacipran |
| US8101643B2 (en) | 2009-02-27 | 2012-01-24 | Enanta Pharmaceuticals, Inc. | Benzimidazole derivatives |
| BRPI1013264A2 (pt) | 2009-03-09 | 2016-04-05 | Novozymes As | processo para reduzir o teor de glicosídeo esteroidal em uma composição, e, uso do processo |
| EP2626350B1 (en) * | 2010-09-22 | 2015-04-15 | Eisai R&D Management Co., Ltd. | Cyclopropane compound |
| WO2013123240A1 (en) * | 2012-02-17 | 2013-08-22 | Eisai R&D Management Co., Ltd | Methods and compounds useful in the synthesis of orexin-2 receptor antagonists |
-
2013
- 2013-02-14 WO PCT/US2013/026204 patent/WO2013123240A1/en not_active Ceased
- 2013-02-14 US US14/379,063 patent/US9416109B2/en active Active
- 2013-02-14 SG SG11201403216UA patent/SG11201403216UA/en unknown
- 2013-02-14 CA CA2861493A patent/CA2861493C/en active Active
- 2013-02-14 MX MX2014009917A patent/MX352881B/es active IP Right Grant
- 2013-02-14 CN CN201380009575.3A patent/CN104114524B/zh active Active
- 2013-02-14 JP JP2014557781A patent/JP6147279B2/ja active Active
- 2013-02-14 BR BR112014019909A patent/BR112014019909B1/pt active IP Right Grant
- 2013-02-14 HU HUE13706874A patent/HUE043995T2/hu unknown
- 2013-02-14 RU RU2014137470A patent/RU2617696C2/ru active
- 2013-02-14 EP EP13706874.8A patent/EP2814798B1/en active Active
- 2013-02-14 ES ES13706874T patent/ES2733750T3/es active Active
-
2014
- 2014-06-02 IL IL232949A patent/IL232949A/en active IP Right Grant
-
2016
- 2016-05-19 US US15/158,687 patent/US9828336B2/en active Active
-
2017
- 2017-10-24 US US15/791,814 patent/US20180044285A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008057575A2 (en) * | 2006-11-07 | 2008-05-15 | Dov Pharmaceutical, Inc. | Novel arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use |
| WO2008150364A1 (en) * | 2007-05-23 | 2008-12-11 | Merck & Co., Inc. | Cyclopropyl pyrrolidine orexin receptor antagonists |
Non-Patent Citations (2)
| Title |
|---|
| Construction of a cis-Cyclopropane via Reductive Radical Decarboxylation. Enantioselective Synthesis of cis- and Antidopaminergic Agents;Kazuya Yamaguchi et al.;《J.Org.Chem.》;20031106;第68卷;9255-9262 * |
| The Effect of Ring Nitrogen Atoms on the Homolytic Reactivity of Phenolic Compounds: Understanding the Radical-Scavenging Ability of 5-Pyrimidinols;Luca Valgimigli et al.;《Chem.Eur.J.》;20031231;第9卷;4997-5010 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3983340B1 (en) * | 2019-06-12 | 2023-08-02 | Nouryon Chemicals International B.V. | Method for isolating carboxylic acid from an aqueous side stream |
| US11976034B2 (en) | 2019-06-12 | 2024-05-07 | Nouryon Chemicals International B.V. | Process for the production of diacyl peroxides |
| US11976035B2 (en) | 2019-06-12 | 2024-05-07 | Nouryon Chemicals International B.V. | Process for the production of diacyl peroxides |
| US12209065B2 (en) | 2019-06-12 | 2025-01-28 | Nouryon Chemicals International B.V. | Process for the production of diacyl peroxides |
| US12215074B2 (en) | 2019-06-12 | 2025-02-04 | Nouryon Chemicals International B.V. | Process for the production of peroxyesters |
| CN119930526A (zh) * | 2025-04-07 | 2025-05-06 | 东北制药集团股份有限公司 | 一种莱博雷生中间体的制备方法 |
| CN119930526B (zh) * | 2025-04-07 | 2025-07-08 | 东北制药集团股份有限公司 | 一种莱博雷生中间体的制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| US9416109B2 (en) | 2016-08-16 |
| EP2814798A1 (en) | 2014-12-24 |
| MX352881B (es) | 2017-12-13 |
| BR112014019909A8 (pt) | 2017-07-11 |
| CA2861493C (en) | 2019-09-24 |
| US20150025237A1 (en) | 2015-01-22 |
| MX2014009917A (es) | 2014-11-13 |
| BR112014019909A2 (enExample) | 2017-06-20 |
| US20160318858A1 (en) | 2016-11-03 |
| HUE043995T2 (hu) | 2019-09-30 |
| SG11201403216UA (en) | 2014-12-30 |
| JP6147279B2 (ja) | 2017-06-14 |
| JP2015509939A (ja) | 2015-04-02 |
| WO2013123240A1 (en) | 2013-08-22 |
| US20180044285A1 (en) | 2018-02-15 |
| CN104114524A (zh) | 2014-10-22 |
| IL232949A0 (en) | 2014-08-03 |
| BR112014019909B1 (pt) | 2020-01-28 |
| EP2814798B1 (en) | 2019-04-03 |
| US9828336B2 (en) | 2017-11-28 |
| RU2617696C2 (ru) | 2017-04-26 |
| IL232949A (en) | 2016-08-31 |
| ES2733750T3 (es) | 2019-12-02 |
| RU2014137470A (ru) | 2016-04-10 |
| CA2861493A1 (en) | 2013-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104114524B (zh) | 用于食欲肽-2受体拮抗剂的合成的方法和化合物 | |
| JP2014051492A (ja) | ジアミン誘導体の製造法 | |
| EP1953159A1 (en) | 6-Benzyl-2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds useful as PDE5 inhibitors | |
| KR20160045797A (ko) | 리소포스파티드산 수용체 길항제로서의 아미드 유도체 | |
| JP2024506182A (ja) | ヒドロキシヘテロシクロアルカン－カルバモイル誘導体 | |
| JP2023547241A (ja) | ガレクチン－３を阻害する２－ヒドロキシシクロアルカン－１－カルバモイル誘導体 | |
| CA3115472A1 (en) | Compounds and compositions for treating conditions associated with apj receptor activity | |
| EP2985286B1 (en) | Midbody of ticagrelor and preparation method therefor, and preparation method for ticagrelor | |
| EP3334735B1 (en) | Processes for preparing an fgfr inhibitor | |
| CN1785976A (zh) | 一类n－烃基青藤碱及其制备方法 | |
| CN118598812A (zh) | 石杉碱甲关键中间体的合成方法 | |
| WO2012051450A1 (en) | Method of making azaindazole derivatives | |
| US8816085B2 (en) | Methylpyrrolopyridinecarboxamides | |
| TW202235078A (zh) | 自分泌運動因子（ａｕｔｏｔａｘｉｎ）之新穎的抑制劑 | |
| TWI904194B (zh) | 作為cftr調節劑之巨環 | |
| US20200172514A1 (en) | Processes for the Preparation of Veliparib and Intermediates Thereof | |
| CN102627684A (zh) | 一种5-氯-6β,19-环氧-5α-雄甾(烷)-3,17-二酮的合成方法 | |
| JP2025537627A (ja) | セレン含有複素環式化合物およびその使用 | |
| JP2025528916A (ja) | Ｊａｋキナーゼ阻害剤のプロドラッグ | |
| WO2005003134A1 (en) | A novel process for the preparation of cilazapril | |
| WO2019164778A1 (en) | Process for preparing 1-arylsulfonyl-pyrrolidine-2-carboxamide transient receptor potential channel antagonist compounds and crystalline forms thereof | |
| WO2010015585A1 (en) | 6-benzyl-2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds | |
| CN104520272A (zh) | 新型多奈哌齐衍生物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |